Assets

Exploring the Potential of C1q in Autoimmunity and Therapeutics

Written by Svar Life Science | Apr 9, 2025 9:00:00 AM

In recent years, research on the complement system has achieved significant breakthroughs, particularly concerning the central protein C1q. Recognized as a vital initiator of the classical complement pathway, C1q also plays diverse roles in autoimmunity, inflammation, the progression of infectious diseases, and the development of therapeutic antibodies.

Meet the Experts
We had the privilege of speaking with Professor Dr. Leendert Trouw and Dr. Douwe Dijkstra, leaders in the field of C1q research. Their insights delve into the critical functions of C1q and the implications of anti-C1q autoantibodies.